Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone.

@article{Wirostko2015NovelTT,
  title={Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone.},
  author={Barbara M. Wirostko and MaryJane Rafii and David A. Sullivan and Julia Morelli and Juan Ding},
  journal={The ocular surface},
  year={2015},
  volume={13 3},
  pages={204-212.e1}
}
Impaired corneal wound healing that occurs with ocular surface disease, trauma, systemic disease, or surgical intervention can lead to persistent corneal epithelial defects (PCED), which result in corneal scarring, ulceration, opacification, corneal neovascularization, and, ultimately, visual compromise and vision loss. The current standard of care can include lubricants, ointments, bandage lenses, amniotic membranes, autologous serum eye drops, and corneal transplants. Various inherent… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 98 references

Corneal Epithelial Wound Healing.

Progress in molecular biology and translational science • 2015

Hystem, a bio-absorbable protein delivery polymer: safety, tolerability and efficacy in a rabbit corneal debridement model

MJ Rafii, B Wirostko, L Werner
Invest Ophthalmol Vis Sci 2013;54:E-Abstract 5048 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT • 2013

Concise review: limbal stem cell deficiency, dysfunction, and distress.

Stem cells translational medicine • 2012
View 1 Excerpt

Similar Papers

Loading similar papers…